This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nagiec, E. E.
Right arrow Articles by Leach, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagiec, E. E.
Right arrow Articles by Leach, K. L.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, September 2005, p. 3896-3902, Vol. 49, No. 9
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.9.3896-3902.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Oxazolidinones Inhibit Cellular Proliferation via Inhibition of Mitochondrial Protein Synthesis

Eva E. Nagiec,2 Luping Wu,1 Steve M. Swaney,1 John G. Chosay,1 Daniel E. Ross,1 Joan K. Brieland,1 and Karen L. Leach1*

Department of Antibacterial Pharmacology, Pfizer, Ann Arbor, Michigan,1 Department of Cardiovascular Cellular and Molecular Pharmacology, Pfizer, St. Louis, Missouri2

Received 1 March 2005/ Returned for modification 3 April 2005/ Accepted 27 May 2005

The oxazolidinones are a relatively new structural class of antibacterial agents that act by inhibiting bacterial protein synthesis. The oxazolidinones inhibit mitochondrial protein synthesis, as shown by [35S]methionine incorporation into intact rat heart mitochondria. Treatment of K562 human erythroleukemia cells with the oxazolidinone eperezolid resulted in a time- and concentration-dependent inhibition of cell proliferation. The cells remained viable, but an increase in doubling time was observed with eperezolid treatment. Inhibition was reversible, since washing and refeeding of cells in the absence of compound resulted in a resumption of growth. The growth-inhibitory effect of the oxazolidinones did not appear to be cell type specific, and inhibition of CHO and HEK cells also was demonstrated. Treatment of cells resulted in a decrease in mitochondrial cytochrome oxidase subunit I levels, consistent with an inhibition of mitochondrial protein synthesis. Eperezolid caused no growth inhibition of rho zero ({rho}0) cells, which contain no mitochondrial DNA; however, the growth of the parent 143B cells was inhibited. These results provide a direct demonstration that the inhibitory effect of eperezolid in mammalian cells is the result of mitochondrial protein synthesis inhibition.

* Corresponding author. Mailing address: 2800 Plymouth Rd., Ann Arbor, MI 48105. Phone: (734) 622-7343. Fax: (734) 622-7158. E-mail: karen.l.leach{at}pfizer.com.

Antimicrobial Agents and Chemotherapy, September 2005, p. 3896-3902, Vol. 49, No. 9
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.9.3896-3902.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Madariaga, M. G., Swindells, S., McKee, E. E. (2007). Oxazolidinones and Human Immunodeficiency Virus. Antimicrob. Agents Chemother. 51: 1130-1130 [Full Text]  
  • Garrabou, G., Soriano, A., Lopez, S., Guallar, J. P., Giralt, M., Villarroya, F., Martinez, J. A., Casademont, J., Cardellach, F., Mensa, J., Miro, OÒs. (2007). Reversible Inhibition of Mitochondrial Protein Synthesis during Linezolid-Related Hyperlactatemia. Antimicrob. Agents Chemother. 51: 962-967 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»